2024 annual financial data
MiNK Therapeutics 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -10,650,239 USD and net income was -10,784,802 USD.
Operating cash flow was -9,555,476 USD.
Get free MiNK Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,650,239 USD
- Net income
- -10,784,802 USD
- Operating cash flow
- -9,555,476 USD